LBF20303PG06

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1725
LipidMaps	LMFA03010045
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20303PG06

Prostaglandin I3
Structural Information
Systematic Name	(6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (5-cis,13-trans,17-cis) -trien-1-oic acid
Common Name	Prostaglandin I3 (6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid
Symbol
Formula	C20H30O5
Exact Mass	350.20932407
Average Mass	350.4492
SMILES	C(=CC[C@@H](O)C=C[C@H]([C@H]12)[C@H](O)C[C@H](O[C@@H](C2)C=CCCC(O)=O)1)CC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source	PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase.
Chemical Synthesis
Metabolism
Biological Activity	PGI3 has equal ability to PGI2 in inhibitting human platelet aggregation. Mann_NJ et al.
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20303PG06 See above. Mann_NJ et al. 1994